“In April, an expert advisory panel for the FDA voted unanimously to recommend Epidiolex’s approval and determined that ‘CBD has a negligible abuse potential.’ The DEA did not immediately respond to Ars’ request for comment. But GW said it expects that the DEA will reschedule CBD within 90 days.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Congress Uses 'The Troops' to Waste Your Money
Trace Mayer on all things Bitcoin
Ignoring Drug Advisors, Britain Bans Khat
Police Imposing Death Sentence Without Trial
Tuna Drone Joins Homeland Security Arsenal
Connections Between Michael Hastings, Edward Snowden and Barrett Brown
NSA building a ‘quantum computer’ to break all forms of encryption
Out of Top 100 News Outlets, Not a Single One Questioned Syrian Attack
Facebook Monitors Private Messages and Photos, Reports to Police
Czech communists to return in office for first time since 1989
FATCA Reciprocity Will Now Target Delaware?
U.S. government waging war on school bake sales?
Filmmakers fighting “Happy Birthday” copyright find their “smoking gun”
Kinda Surprised This Doesn't Happen More Often
Professor Maintains List of 400,000 "Far-Right Extremists" For Antifa, SPLC